The impairment may be mediated by the following mechanisms: immunosuppressing factors released by tumor cells, deficient tumor antigen presentation by dendritic cells, reduced production of costimulating cytokines by helper CD4+ T-cells, and recruitment of regulatory immune cells by tumor cells [35]. This evidence concerns the gene CD4 and neoplasm.